ID SPI_SCHGR Reviewed; 83 AA. AC P85064; DT 09-JAN-2007, integrated into UniProtKB/Swiss-Prot. DT 29-APR-2015, sequence version 3. DT 24-JAN-2024, entry version 37. DE RecName: Full=Greglin; OS Schistocerca gregaria (Desert locust) (Gryllus gregarius). OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; OC Neoptera; Polyneoptera; Orthoptera; Caelifera; Acrididea; Acridomorpha; OC Acridoidea; Acrididae; Cyrtacanthacridinae; Schistocerca. OX NCBI_TaxID=7010; RN [1] RP PROTEIN SEQUENCE, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND RP PHOSPHORYLATION AT SER-8; SER-11 AND SER-15. RC TISSUE=Ovary {ECO:0000269|PubMed:16839309}; RX PubMed=16839309; DOI=10.1042/bj20060437; RA Brillard-Bourdet M., Hamdaoui A., Hajjar E., Boudier C., Reuter N., RA Ehret-Sabatier L., Bieth J.G., Gauthier F.; RT "A novel locust (Schistocerca gregaria) serine protease inhibitor with a RT high affinity for neutrophil elastase."; RL Biochem. J. 400:467-476(2006). RN [2] RP PROTEIN SEQUENCE, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MASS RP SPECTROMETRY, DISULFIDE BONDS, PHOSPHORYLATION AT SER-8, AND X-RAY RP CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 21-78 IN COMPLEX WITH SUBTILISIN. RC TISSUE=Ovary {ECO:0000303|PubMed:23075397}; RX PubMed=23075397; DOI=10.1111/febs.12033; RA Derache C., Epinette C., Roussel A., Gabant G., Cadene M., Korkmaz B., RA Gauthier F., Kellenberger C.; RT "Crystal structure of greglin, a novel non-classical Kazal inhibitor, in RT complex with subtilisin."; RL FEBS J. 279:4466-4478(2012). CC -!- FUNCTION: Serine protease inhibitor (PubMed:16839309, PubMed:23075397). CC Inhibits porcine pancreatic elastase with a Ki of 58.3 nM, human CC neutrophil elastase with a Ki of 3.6 nM, cathepsin G with a Ki of 153.5 CC nM, chymotrypsin with a Ki of 26.7 nM and subtilisin with a Ki of 0.68 CC nM. Does not inhibit neutrophil protease 3 or pancreatic trypsin CC (PubMed:16839309). {ECO:0000269|PubMed:16839309, CC ECO:0000269|PubMed:23075397}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC No decrease in activity observed after incubating at pH 2.5, pH 7.4 CC and at pH 11.0 for 1 hour to overnight (PubMed:16839309, CC PubMed:23075397). {ECO:0000269|PubMed:16839309, CC ECO:0000269|PubMed:23075397}; CC Temperature dependence: CC Thermostable (PubMed:16839309, PubMed:23075397). No decrease in CC activity was observed after heating for 1 hour at up to 95 degrees CC Celsius (PubMed:16839309, PubMed:23075397). CC {ECO:0000269|PubMed:16839309, ECO:0000269|PubMed:23075397}; CC -!- MASS SPECTROMETRY: Mass=9661.13; Method=Electrospray; CC Evidence={ECO:0000269|PubMed:23075397}; CC -!- MASS SPECTROMETRY: Mass=9733.08; Method=Electrospray; Note=Mono- CC phosphorylated form.; Evidence={ECO:0000269|PubMed:23075397}; CC -!- MASS SPECTROMETRY: Mass=9813.06; Method=Electrospray; Note=Di- CC phosphorylated form.; Evidence={ECO:0000269|PubMed:23075397}; CC -!- MASS SPECTROMETRY: Mass=9893.04; Method=Electrospray; Note=Tri- CC phosphorylated form.; Evidence={ECO:0000269|PubMed:23075397}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR PDB; 4GI3; X-ray; 1.75 A; C=1-83. DR PDBsum; 4GI3; -. DR AlphaFoldDB; P85064; -. DR SMR; P85064; -. DR IntAct; P85064; 1. DR MINT; P85064; -. DR MEROPS; I01.059; -. DR iPTMnet; P85064; -. DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW. DR Gene3D; 3.30.60.30; -; 1. DR InterPro; IPR036058; Kazal_dom_sf. DR SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disulfide bond; Phosphoprotein; KW Protease inhibitor; Serine protease inhibitor. FT CHAIN 1..83 FT /note="Greglin" FT /id="PRO_0000271408" FT MOD_RES 8 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:16839309, FT ECO:0000269|PubMed:23075397" FT MOD_RES 11 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:16839309" FT MOD_RES 15 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:16839309" FT DISULFID 21..55 FT /evidence="ECO:0000269|PubMed:23075397" FT DISULFID 25..48 FT /evidence="ECO:0000269|PubMed:23075397" FT DISULFID 33..69 FT /evidence="ECO:0000269|PubMed:23075397" FT DISULFID 53..76 FT /evidence="ECO:0000269|PubMed:23075397" FT CONFLICT 7 FT /note="A -> V (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 17..25 FT /note="TELPCPSIC -> LELPLPSIS (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 39 FT /note="Q -> S (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT STRAND 24..26 FT /evidence="ECO:0007829|PDB:4GI3" FT STRAND 32..36 FT /evidence="ECO:0007829|PDB:4GI3" FT STRAND 41..46 FT /evidence="ECO:0007829|PDB:4GI3" FT HELIX 47..57 FT /evidence="ECO:0007829|PDB:4GI3" FT STRAND 61..63 FT /evidence="ECO:0007829|PDB:4GI3" FT HELIX 66..68 FT /evidence="ECO:0007829|PDB:4GI3" SQ SEQUENCE 83 AA; 9195 MW; CFEAA69ABDCC39EF CRC64; SEDDGSASPE SQEMSYTELP CPSICPLIYA PVCVEDSNQD FYLFVNECEV RKCGCEAGFV YTFVPREMCK ATTSLCPMQT KSS //